Dose Ranging Study of Celivarone With Amiodarone as Calibrator for the Prevention of Implantable Cardioverter Defibrillator Interventions or Death - ALPHEE


The current trial was a phase II dose-ranging trial to study the safety and efficacy of celivarone as compared with amiodarone and placebo in patients with cardiomyopathy and recent implantable cardioverter defibrillator (ICD) therapy. Celivarone is a new AAD with Vaughn Williams Class I-IV effects.